Creative medical technology holdings expands collaboration with greenstone biosciences to accelerate ipscelz pipeline development

Phoenix, feb. 05, 2025 (globe newswire) -- creative medical technology holdings, inc. (nasdaq: celz) (“creative medical”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced an expanded agreement with greenstone biosciences inc. (“greenstone”) to leverage artificial intelligence (ai) in further developing its human induced pluripotent stem cell (ipsc) platform for diabetes treatment.
CELZ Ratings Summary
CELZ Quant Ranking